David A. Lipson
Pulmonary Medicine
3400 Civic Center Boulevard
West Pavilion, 1st Floor
Philadelphia, PA 19104
West Pavilion, 1st Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
The Effect of Patient Sex on Treatment Outcomes in COPD: A Post Hoc Analysis of the IMPACT Trial.
Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)
Published: November 12, 2024
Effects of seasonality and treatment on COPD clinical outcomes: IMPACT post hoc analysis.
Journal: ERJ open research
Published: June 07, 2024
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD.
Journal: The European respiratory journal
Published: January 23, 2024
Any Decrease in Lung Function is Associated With Worse Clinical Outcomes: Post Hoc Analysis of the IMPACT Interventional Trial.
Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)
Published: December 11, 2023
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Journal: Chronic respiratory disease
Published: October 06, 2023
Single-cell analysis of the nervous system at small and large scales with instant partitions.
Journal: bioRxiv : the preprint server for biology
Published: July 28, 2023
Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial.
Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)
Published: December 14, 2022
Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial.
Journal: Journal of the American Heart Association
Published: September 14, 2022
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.
Journal: Respiratory medicine
Published: June 26, 2022
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials.
Journal: American journal of respiratory and critical care medicine
Published: April 01, 2022
Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: March 24, 2022
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD.
Journal: Respiratory medicine
Published: February 23, 2022
Last Updated: 09/26/2026